Gait Analysis in Patients With Hemiplegia Using Insole Splint.
NCT ID: NCT05908149
Last Updated: 2024-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
12 participants
INTERVENTIONAL
2023-04-12
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the insole splint improve the gait of these patients? Does any difference exist in the use of muscles?
Participants will have to walk in the gait analysis' aisle with and without the insole splint, using wireless EMG device.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HEMIPLEGIC PATIENTS
HEMIPLEGIC PATIENTS WITH PES EQUINUS WILL BE EXAMINED BY GAIT ANALYSIS WITH AND WITHOUT THE INSOLE SPLINT, RANDOMLY
Insole Splint
Insole splint used in 'Pes equinus' in patients with hemiplegia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insole Splint
Insole splint used in 'Pes equinus' in patients with hemiplegia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must have use the insole splint during physiotherapy sessions for at least 1 week before their inclusion in the trial.
* Patients must be able to communicate and fully understand the instructions given by the researchers.
* Researchers are going to try to have a sex ratio 50/50.
* Patients' age is going to be between 18-70 years.
* Functional Ambulation Category: FAC \> 2
* Modified Ashworth Scale of the affected lower Limb (MAS): MAS ≤2
* Normal Gait before the stroke.
Exclusion Criteria
* Past or ongoing orthopedic or reumatologic disease that bothers patient's gait.
* Past damage of the Central Nervous System.
* Dermatologic problems or human factors that limitate the use of insole splint.
* Patients must not have used intramuscular botox injection recently.
* Patients with low motivation and low perception are also excluded.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ioannina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Avraam Ploumis
Director of Physical Medicine and Rehabilitation Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Physical Medicine and Rehabilitation, University Hospital of Ioannina
Ioannina, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Avraam Ploumis
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10/12-4-2023 (T.34)
Identifier Type: -
Identifier Source: org_study_id